相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional comparison of PBMCs isolated by Cell Preparation Tubes (CPT) vs. Lymphoprep Tubes
Han Chen et al.
BMC IMMUNOLOGY (2020)
Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators
Ahmad Faisal Karim et al.
FRONTIERS IN IMMUNOLOGY (2020)
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
B. M. Reipert et al.
BLOOD ADVANCES (2020)
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study
Johnny Mahlangu et al.
HAEMOPHILIA (2018)
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
Antonino Cannavo et al.
BLOOD (2017)
Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry
Bo Langhoff Honge et al.
PLOS ONE (2017)
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
F. Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient
Christopher P. Corkum et al.
BMC IMMUNOLOGY (2015)
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans
Christoph J. Hofbauer et al.
BLOOD (2015)
Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL)
Christopher A. Todd et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal
Constance Ducar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
Shawn F. J. Whelan et al.
BLOOD (2013)
Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A
Guenter Auerswald et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Optimization and Limitations of Use of Cryopreserved Peripheral Blood Mononuclear Cells for Functional and Phenotypic T-Cell Characterization
Adriana Weinberg et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres
Virginie Nerich et al.
PHARMACY WORLD & SCIENCE (2008)
European Study on Orthopaedic Status of haemophilia patients with inhibitors
M. Morfini et al.
HAEMOPHILIA (2007)
Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples
Wayne B. Dyer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
ML Disis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
The epidemiology of inhibitors in haemophilia A: a systematic review
J Wight et al.
HAEMOPHILIA (2003)
Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals
F Kern et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
分享论文
